Sort
16,300 grants matching “fatty liver disease”
Novel IL-23 inhibitor for the treatment of alcohol associated liver disease
$711,945Rohit Loomba · University Of California, San Diego · U01 · FY2024 · AA
Long-Acting RNAi Therapy for Atherosclerosis and Insulin Resistance
$711,340Jinjun Shi · Brigham And Women'S Hospital · R01 · FY2021 · HL
Imaging the Vascular Consequences of Lipid Deposition
$710,553James Athur Hamilton · Boston University Medical Campus · P50 · FY2008 · HL
RNA binding proteins in atherosclerosis
$710,427Tamer Sallam · University Of California Los Angeles · R01 · FY2025 · HL
COLLOIDAL IRON-OXIDE NANOBEACONS FOR THERANOSTIC USE IN ATHEROSCLEROSIS
$710,188Gregory M Lanza · Washington University · R01 · FY2010 · HL
Prebiotic effect of eicosapentaenoic acid treatment for colorectal cancer livermetastasis
$710,138Wendy S. Garrett · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2024 · CA
TOPMed Omics of Type 2 Diabetes and Quantitative Traits
$709,961Alisa Knodle Manning · Massachusetts General Hospital · UM1 · FY2024 · DK
Control of cancer cachexia via stimulation of resolution of inflammation
$709,923Dipak Panigrahy · Beth Israel Deaconess Medical Center · R01 · FY2024 · CA
Gut flora metabolism of dietary phosphatidylcholine and cardiovascular disease
$709,072Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2014 · HL
Preventing Diabetes in Latino Youth
$709,015Gabriel Quantum Shaibi · Arizona State University-Tempe Campus · R01 · FY2016 · DK
Liver-Gut-Microbiome Axis and Fatty acid absorption in Preterm Infants
$708,993Amy Boriskie Hair · Baylor College Of Medicine · R01 · FY2023 · DK
Mechanisms connecting dysregulated BCAA, glucose & lipid metabolism in the pathogenesis of metabolic disease
$708,592Christopher B Newgard · Duke University · R01 · FY2019 · DK
Elimination of HCV and related liver disease among HIV-infected and -uninfected people who inject drugs
$708,571David L Thomas · Johns Hopkins University · R01 · FY2020 · DA
The Molecular Profile of Prostate Tumors in African-American Men
$708,426Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Carotid plaque characteristics by MRI in AIM-HIGH
$708,181Xue-Qiao Zhao · University Of Washington · R01 · FY2009 · HL
Liver Cirrhosis Network: Longitudinal and Clinical Trial Studies
$707,682Mandana Khalili · University Of California, San Francisco · U01 · FY2022 · DK
CVD in American Indians Biomarker lab and Arizona Field Center
$707,555Barbara V Howard · Medstar Health Research Institute · R01 · FY2015 · HL
Multimodal omics approach to identify health to cardiometabolic disease transitions
$707,457Paivi Pajukanta · University Of California Los Angeles · R01 · FY2023 · HL
Animal Models for Studying the Genetics of Hypertension
$707,411Oliver Smithies · Univ Of North Carolina Chapel Hill · R01 · FY2009 · HL
Targeting Nonalcoholic Fatty Liver Disease during the reproductive period to improve women's health outcomes
$707,389Tatyana Kushner · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · DK
Regulation of the biosynthesis of a novel class of anti-diabetic lipids
$707,327Barbara B Kahn · Beth Israel Deaconess Medical Center · R01 · FY2019 · DK
Regulation of the biosynthesis of a novel class of anti-diabetic lipids
$707,327Barbara B Kahn · Beth Israel Deaconess Medical Center · R01 · FY2020 · DK
Regulation of the biosynthesis of a novel class of anti-diabetic lipids
$707,327Barbara B Kahn · Beth Israel Deaconess Medical Center · R01 · FY2017 · DK
Multi-omics study of ancestry enriched associations in Hispanics/Latinos
$707,304Nora Franceschini · Univ Of North Carolina Chapel Hill · R01 · FY2024 · HG
ER stress and UPR in non-alcoholic steatohepatitis and hepatocellular carcinoma
$707,261Randal J. Kaufman · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · CA